Trials / Unknown
UnknownNCT00121797
Peripartum Bacteruria and Urinary Tract Infections (UTI)
Risk Factors for Postpartum Bacteruria, Does Labor Cause UTI?
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
In the last years urinary tract infections (UTI) and pyelonephritis have been the most common reason for readmission to our hospital after birth. UTI is know to be one of the leading causes of postpartum fever affecting about 3%-8% of all postpartum women. The investigators hypothesize that collecting urine cultures pre- and postnatally may help identify women at risk for developing UTI, while treating women with positive cultures could decrease the rehospitalization rate due to postpartum fever. Collecting data during delivery may help identify women at risk for this complication.
Detailed description
The study is planned as a randomized controlled study with 500 women in each arm. The study group will have pre and post labor urine cultures taken, and the risk factors during delivery will be documented, while the control group will have no cultures taken, as the common practice prior to the study. Women with positive cultures will be contacted by telephone, and antibiotic treatment recommended according to bacteria sensitivity. All women will be contacted by telephone 1 month post partum and data regarding urinary tract symptoms and need for hospitalization, will be collected. The rehospitalization rate will be documented and compared between the two groups. The assumption is that routine urine culture to women in the peripartum period may reduce the UTI rate and hospitalization after delivery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | urine culture | |
| DRUG | antibiotics according to culture |
Timeline
- Start date
- 2004-01-01
- Completion
- 2005-06-01
- First posted
- 2005-07-21
- Last updated
- 2006-11-07
Locations
2 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT00121797. Inclusion in this directory is not an endorsement.